Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1370545
European Journal of Endocrinology, Vol 137, Issue 5, 545-555
Copyright © 1997 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Briard, N
Right arrow Articles by Oliver, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briard, N
Right arrow Articles by Oliver, C

Articles

Species differences between male rat and ram pituitary somatostatin receptors involved in the inhibition of growth hormone secretion

N Briard, A Dutour, J Epelbaum, N Sauze, A Slama, and C Oliver

Laboratoire de Neuroendocrinologie Experimentale, INSERM U297, Institut Federatif Jean Roche, Marseille, France.

The sheep is a valuable model in which to study GH neuroregulation as its pattern of GH secretion is very close to that in humans. Furthermore, important differences in somatostatin (SRIH) action between rats and sheep have been found previously. Our goal was to compare in male rat and ram pituitaries the binding characteristics of somatostatin receptors and the effect of SRIH and 17 analogues on GH release. Using radioautography, SRIH binding was seen to be evenly distributed over the anterior pituitary of both species. In the binding assay, binding sites were three times more concentrated in rats than in sheep. Important interspecies differences in the action of SRIH and its analogues were found: they inhibited GH at lower concentrations in rats than in sheep. Seven peptides displayed greater inhibitory ability in sheep than in rats while three were more potent in rats. Agonistic potencies to inhibit GH release in rats were correlated with somatostatin receptors subtype 2 (sst2) affinities. Our data confirm and extend the quantitative differences between rat and sheep in SRIH inhibitory action on GH secretion and confirm that ligand-binding properties of a given receptor subtype cannot be extrapolated across species.


This article has been cited by other articles:


Home page
EndocrinologyHome page
R. M. Luque, M. Duran-Prado, S. Garcia-Navarro, F. Gracia-Navarro, R. D. Kineman, M. M. Malagon, and J. P. Castano
Identification of the Somatostatin Receptor Subtypes (sst) Mediating the Divergent, Stimulatory/Inhibitory Actions of Somatostatin on Growth Hormone Secretion
Endocrinology, June 1, 2006; 147(6): 2902 - 2908.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Lanneau, M. T. Bluet-Pajot, P. Zizzari, Z. Csaba, P. Dournaud, L. Helboe, D. Hoyer, E. Pellegrini, G. S. Tannenbaum, J. Epelbaum, et al.
Involvement of the Sst1 Somatostatin Receptor Subtype in the Intrahypothalamic Neuronal Network Regulating Growth Hormone Secretion: An in Vitro and in Vivo Antisense Study
Endocrinology, March 1, 2000; 141(3): 967 - 979.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Djordjijevic, J. Zhang, M. Priam, C. Viollet, D. Gourdji, C. Kordon, and J. Epelbaum
Effect of 17{beta}-Estradiol on Somatostatin Receptor Expression and Inhibitory Effects on Growth Hormone and Prolactin Release in Rat Pituitary Cell Cultures
Endocrinology, May 1, 1998; 139(5): 2272 - 2277.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 European Society of Endocrinology.